Highlights ClearPoint Neuro, Inc.

Equities

CLPT

US18507C1036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
5.89 ^USD	-0.84%		+8.47%	-13.25%

May. 07	ClearPoint Neuro, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 07	Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, vs. Street Est of $7M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ClearPoint Neuro, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, vs. Street Est of $7M	May. 07	MT
ClearPoint Neuro, Inc. Announces FDA Clearance of Prism Bone Anchor Accessory	Apr. 29	CI
ClearPoint Neuro, Inc. Announces Initiation of Limited Market Release for the SmartFrame OR? Stereotactic System	Apr. 24	CI
ClearPoint Neuro Says Partner AviadoBio Treats First Person in Trial of AVB-101 for Frontotemporal Dementia	Apr. 16	MT
ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Earnings Flash (CLPT) CLEARPOINT NEURO Posts Q4 Revenue $6.8M, vs. Street Est of $6.5M	Mar. 12	MT
ClearPoint Neuro, Inc. Reaffirms Revenue Guidance for the Year 2024	Mar. 12	CI
ClearPoint Neuro, Inc. Announces Preclinical Results of an in Vivo Validation Study Have Been Published in the Journal of Neurosurgery	Mar. 11	CI
ClearPoint Neuro to Seek Acquisitions	Mar. 01	CI
ClearPoint Neuro, Inc. Announces FDA Clearance and First-In-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model	Feb. 21	CI
ClearPoint Neuro, Inc. Announces Installation and First Procedure Using the Clearpoint Prism® Neuro Laser Therapy System and Navigation System At Kaleida Health in Buffalo	Jan. 24	CI
Clearpoint Neuro Receives 510(K) Clearance for Smartframe or Stereotactic System	Jan. 16	CI
ClearPoint Neuro Shares Up 16% After Prelim. 4Q Revenue Beats Estimates	Jan. 09	DJ
Clinical Laserthermia Systems Gets SEK8 Million Order from ClearPoint Neuro; Stocks Rise	Jan. 09	MT
ClearPoint Neuro, Inc. Provides Revenue Guidance for the Full Year 2024	Jan. 08	CI
ClearPoint Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q3 Revenue $5.8M, vs. Street Est of $6.73M	Nov. 09	MT
ClearPoint Neuro, Inc. Provides Earnings Guidance for the Year 2023	Nov. 09	CI
ClearPoint Neuro, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ClearPoint Neuro, Inc.

Equities

CLPT

US18507C1036

Highlights

Filters